Imaging biomarkers serve as important end points for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies.
Imaging Biomarkers in Clinical Trials
Apr 24th, 2014Apr 25th, 2014
Latest in Home
Radiation exposure low during TARE procedures
March 17, 2026
Study supports use of SPECT in Pluvicto patients
March 16, 2026















